Intranasal Insulin in Frontotemporal Dementia (FTD)
NCT04115384
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
3
Enrollment
OTHER
Sponsor class
Stopped
COVID - unable to restart after restrictions were lifted
Conditions
Frontotemporal Dementia, Behavioral Variant
Interventions
DRUG:
Novolin-R insulin
Sponsor
HealthPartners Institute